Vertex Pharmaceuticals Incorporated Shares Outstanding 2008–2025
Vertex Pharmaceuticals Incorporated reported 254.0M of shares outstanding for fiscal 2025. That was 1.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -2.3%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 254.0M | -1.1% |
| FY 2024 | 256.9M | -0.3% |
| FY 2023 | 257.7M | +0.3% |
| FY 2022 | 257.0M | +1.0% |
| FY 2021 | 254.5M | -2.1% |
| FY 2020 | 259.9M | +0.3% |
| FY 2019 | 259.0M | +1.5% |
| FY 2018 | 255.2M | +0.8% |
| FY 2017 | 253.3M | +2.0% |
| FY 2016 | 248.3M | +0.8% |
| FY 2015 | 246.3M | +1.9% |
| FY 2014 | 241.8M | +3.4% |
| FY 2013 | 233.8M | +7.6% |
| FY 2012 | 217.3M | +3.8% |
| FY 2011 | 209.3M | +2.8% |
| FY 2010 | 203.5M | +1.8% |
| FY 2009 | 200.0M | — |
| FY 2008 | 0.0M | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open VRTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Vertex Pharmaceuticals Incorporated reported 254.0M of shares outstanding for fiscal 2025. That was 1.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -2.3%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's shares outstanding?
Vertex Pharmaceuticals Incorporated (VRTX) reported shares outstanding of 254.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More VRTX financial history
Full VRTX fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →